$PRSO·8-K

Peraso Inc. · Jul 2, 5:13 PM ET

Compare

Peraso Inc. 8-K

Research Summary

AI-generated summary

Updated

Peraso Inc. Enters $25M Equity Purchase Agreement with Roth Principal

What Happened
Peraso Inc. announced on June 30, 2026 that it entered into a Common Stock Purchase Agreement and a related Registration Rights Agreement with Roth Principal Investments, LLC. Subject to the satisfaction of conditions (including an effective SEC registration statement), Peraso may, at its option, sell up to $25,000,000 of newly issued common stock to Roth Principal over a period of up to 36 months beginning on the Commencement Date (the date the registration statement is declared effective). The company issued a press release about the transaction on July 2, 2026.

Key Details

  • Maximum commitment: up to $25,000,000 of common stock purchases by Roth Principal; purchases are at Peraso’s election and not required.
  • Timing/term: purchases may occur from Commencement (when the Registration Statement is effective) for up to 36 months.
  • Nasdaq/ownership limits: cannot issue more than 3,004,114 shares under the agreement (19.99% of outstanding shares prior to the agreement) unless stockholder approval or a qualifying average price condition (~$0.9853) is met; Roth (with affiliates) may not beneficially own more than 4.99%.
  • Pricing mechanics: purchases reference VWAP (various intraday/pre/post sessions) with fixed discounts—Market Open and Intraday purchases use a 3.0% discount to VWAP; Pre- and Post-Market purchases use a 6.0% discount. There is no stated upper limit on the per-share price Roth could pay.
  • Fees/reimbursements: Peraso agreed to pay a $500,000 commitment fee (funded by Roth withholding 10% of purchase proceeds until withheld amounts total $500,000), reimburse $100,000 in Roth’s legal fees upon execution, up to $7,500 per fiscal quarter for bring-down legal work, and up to $50,000 for the qualified independent underwriter’s fees.
  • Other restrictions: Peraso agreed to limited restrictions on certain variable-rate equity transactions during the agreement and agreed not to sell shares (with limited exceptions) prior to effectiveness of the Registration Statement without Roth’s consent.

Why It Matters
This agreement gives Peraso a committed equity financing source of up to $25 million that the company can draw on over time to fund working capital, product development, and market expansion (including drone, defense and tactical communications efforts), while retaining control over the timing and amount of any sales. For investors, the deal can mean potential dilution if and when shares are issued under the facility, subject to Nasdaq ownership limits and Peraso’s discretion. The pricing mechanics (VWAP-based with discounts) and the commitment-fee structure affect the net proceeds Peraso would receive from any sales under the agreement.

Loading document...